Fibroblast Growth Factor 23 and the Last Mile

Clin J Am Soc Nephrol. 2020 Sep 7;15(9):1355-1357. doi: 10.2215/CJN.13631119. Epub 2020 Apr 10.
No abstract available

Keywords: Diagnostic Tests; Fibroblast Growth Factors; Routine; cardiovascular disease; fibroblast growth factor 23; hyperphosphatemia; mineral metabolism.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Biomarkers / blood
  • Chronic Kidney Disease-Mineral and Bone Disorder / blood*
  • Chronic Kidney Disease-Mineral and Bone Disorder / diagnosis
  • Chronic Kidney Disease-Mineral and Bone Disorder / drug therapy
  • Chronic Kidney Disease-Mineral and Bone Disorder / physiopathology
  • Fibroblast Growth Factor-23 / blood*
  • Humans
  • Hyperparathyroidism, Secondary / blood*
  • Hyperparathyroidism, Secondary / diagnosis
  • Hyperparathyroidism, Secondary / drug therapy
  • Hyperparathyroidism, Secondary / physiopathology
  • Kidney / drug effects
  • Kidney / metabolism
  • Kidney / physiopathology*
  • Phosphorus / blood
  • Renal Agents / therapeutic use
  • Renal Insufficiency, Chronic / blood*
  • Renal Insufficiency, Chronic / diagnosis
  • Renal Insufficiency, Chronic / drug therapy
  • Renal Insufficiency, Chronic / physiopathology
  • Vitamin D / analogs & derivatives
  • Vitamin D / blood

Substances

  • Biomarkers
  • FGF23 protein, human
  • Renal Agents
  • Vitamin D
  • Phosphorus
  • 1,25-dihydroxyvitamin D
  • Fibroblast Growth Factor-23